Spectrofluorimetric determination of labetalol in pharmaceutical preparations and biological fluids

Journal of Food and Drug Analysis

Volumn 14, Issue 2, 2006, Pages 133-140

  El Wasseef, Dodomum R ^a   El Ashry, S M ^a   Abu El Enein, M A ^a   Moustafa, M A A ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Biological fluids; Labetalol 2 cyanoacetamide; Pharmaceutical preparations; Spectrofluorimetry

Indexed keywords

ACETAMIDE DERIVATIVE; AMMONIA; CYANOACETAMIDE; LABETALOL; NITROSO DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BODY FLUID; CALIBRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG STRUCTURE; DRUG URINE LEVEL; HUMAN; IN VITRO STUDY; LINEAR SYSTEM; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; REFERENCE VALUE; SENSITIVITY ANALYSIS; SPECTRAL SENSITIVITY; SPECTROFLUOROMETRY; TABLET FORMULATION;

EID: 33747363430     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Parfitt, K. (ed.) 1999. Martindale. In "The Complete Drug Reference". 32nd ed. pp. 896-897. Massachusetts, U. S. A.
2. The British Pharmacopoeia. 1998. pp. 768-769. Her Majesty Stationary Office. London, U. K.
3. The United States Pharmacopia 27. 2004. National Formulary, U.S. pp. 1060-1062. Pharmacopial Convention. Rockville, MD, U. S. A.
4. The European Pharmacopoeia. 2001. p. 1039. Council of Europe. Strasburg.
5. Belal, F., Al-Shaboury, S. and Al-Tamrah, A. S. 2003. Spectrophotometric determination of labetalol in pharmaceutical preparations and spiked human urine. II Farmaco 58: 293-299.
6. Sastry, C. S. P. and Krishna, D. M. 1996. Spectrophotometric methods for the determination of labetalol hydrochloride in pure and dosage forms. Mikrochim. Acta 122: 87-93.
7. Rao, G. R. and Raghuveer, S. 1986. Colorimetric determination of labetalol hydrochloride in pharmaceutical dosage forms. Indian Drugs 23: 626-629.
8. Sane, R. T., Chandrashekar, T. G. and Nayak, V. G. 1986. Simple spectrophotometric methods for the determination of labetalol hydrochloride. Indian Drugs 23: 565-568.
9. Abdine, H., Sultan, M. A. and Hefhawy, M. M. 2005. Spectrofluorimetric determination of some β-blockers in tablets and human plasma using 9,10-dimethoxyanthracene-2-sodium sulfonate. Pharmazie 60: 265-268
10. Belal, F., Al-Shaboury, S. and Al-Tamrah, A. S. 2002. Spectrofluorometric determination of labetolol in pharmaceutical preparations and spiked human urine through the formation of coumarin derivative J. Pharm. Biomed. Anal. 30: 1191-1196.
11. Mohamed, M. E. 1983. Fluorimetric and spectrophotometric determination of labetalol hydrochloride and its tablets. Pharmazie 38: 784-785.
12. Magali, D., Charlotte, D., Frangois, P., Philippe, D. and Jean-Claude, A. 2004. Simultaneous determination of thirteen β-blockers and one metabolite by gradient high-performance liquid chromatography with photodiode-array UV detection. Forensic Sci. Int. 141: 23-31.
13. Zhao, H., Li, H. Z. and Qiu, Z. Y 1999. Separation of enantiomeric labetalol by reversed-phase high performance liquid chromatography. Sepu 17: 369-371.
14. Musch, G., Buelens, Y. and Massart, D. L. 1989. A strategy for the determination of beta blockers in plasma using solid-phase extraction in combination with high-performance liquid chromatography J. Pharm. Biomed. Anal. 7: 483-497.
15. Dakers, J. M., Boulton, D. W. and Fawcett, J. P. 1997. Sensitive chiral high-performance liquid chromatographic assay for labetalol in biological fluids J. Chromatogr. B 704: 215-220.
16. Ceniceros, C., Maguregui, M. I., Jimenez, R. M. and Alonso, R. M. 1998. Quantitative determination of the β-blocker labetalol in pharmaceuticals and human urine by high-performance liquid chromatography with amperometric detection J. Chromatogr. B 705: 97-103.
17. Plavsic, F., Stavljevic, A. and Wolf-Coporda, A. 1989. Determination of labetalol in biological material using high-performance liquid chromatography with electrochemical detection. Acta. Pharm. Jugosl. 39: 69-72.
18. Lant, M. S. and Martin, J. O. E. 1987. Automated sample preparation on-line with thermospray high-performance liquid chromatography - mass spectrometry for the determination of drugs in plasma. J. Chromatogr. A 394: 223.
19. Mario, T., Georg, O. and Wilhelm, S. 2001. High speed determination of beta-receptor blocking agents in human urine by liquid chromatography/ tandem mass spectrometry Biomed. Chromatogr. 15: 393-402.
20. Gergov, M., Robson, J. N. Duchoslav, E. and Ojanpera, I. 2000. Automated liquid chromatographic/tandem mass spectrometric method for screening β-blocking drugs in urine. J. Mass Spectrom. 35: 912-918.
21. Carda-Broch, S., Rapado-Martinez, R., Esteve-Romero, I. and Garcia-Alvarez-Coque, M. C. 1999. Analysis of urine samples containing cardiovascular drugs by micellar liquid chromatography with fluorimetric detection. J. Chromatogr. Sci. 37: 93-102.
22. Rapado-Martínez, I, García-Alvarez-Coque, M. C. and Villanueva-Camañas, R. M. 1997. Liquid chromatographic procedure for the evaluation of β-blockers in pharmaceuticals using hybrid micellar mobile phases. J. Chromatogr. A 765: 221-231.
23. Karlsson, C., Wikstrom, H., Armstrong, D. W. and Owens, P. K. 2000. Enantioselective reversed-phase and non-aqueous capillary electrochromatography using a teicoplanin chiral stationary phase. J. Chromatogr. A 897: 349-363.
24. Goet, T. V., Nikelly, J. G., Simpson, R. C. and Matuszewski, B. K. 2004. Chiral separation of labetalol stereoisomers in human plasma by capillary clectrophoresis J. Chromatogr. A 1027: 213-221.
25. Tamisier-Karotak, S. L., Stenger, M. A. and Bommart, A. 1999. Enantioseparation of β-blockers with two chiral centers by capillary electrophoresis using sulfated β-cyclodextrins. Electrophoresis 20: 2656-2663.
26. Wang, F. and Khaledi, M. G. 1998. Capillary electrophoresis chiral separations of basic compounds using cationic cyclodextrin. Electrophoresis 19: 2095-2100.
27. Jana, S. and Jozef, P. 1996. Determination of some cardiovascular drugs in serum and urine by capillary isotachophoresis J. Chromatogr. A 735: 403-408.
28. Iorio, M. A. Mazzeo-Farina, A. and Doldo, A. 1987. Quantitative analysis of β-adrenergic blocking agents by NMR spectroscopy J. Pharm. Biomed. Anal. 5: 1-10.
29. Gorodkiewicz, E. Falkowski, P. Sankiewicz, A. and Figaszewski, Z. 2003. Analytical applications of electrode sensitive to labetalol in pharmaceuticals. Central Euro. J. Chem. 1: 242-259.
30. Liu, Y., Yang, J., Wu, X. and Li, L. 2003. Fluorometric Determination of 3,4-Dihydroxyphenylalanine with 2-Cyanoacetamide. J. Fluorescence 13: 123-128.
31. Aly, F. A. 1999. Spectrofluorimetric determination of prenalterol hydrochloride in pharmaceutical preparations and biological fluids. J. Pharm. Biomed. Anal. 18: 993-997.
32. Rizk, M., Belal, F., Ibrahim, F., Ahmed, S. M. and el-Enany, N. M. 1999. Fluorimetric determination of oxamniquine in biological fluids. II Farmaco 54: 47-50.
33. Yang, J., Ma, Q. L., Huang, F., Sun, L. and Dong, J. 1998. A New fluorimetric method for the determination of ascorbic acid. Anal. Lett. 31: 2757-2766.
34. Miller, J. C. and Miller, J. N. 1983. Statistics for Analytical Chemistry. P. 83. Wiley. New York. U. S. A.
35. March, J. 1992. Advanced Organic Chemistry: Reactions, Mechanism and Structure. 2nd ed. pp. 593-594. John Wiley and sons. U. S. A.
36. Alfonso, R. G. 2000. Remington: The Science and Practice of Pharmacy. 20th ed. pp. 135-140. Lipincott Williams and Wilkins.